How much funding has Nanoscribe raised?

Nanoscribe has raised $86.5M in total funding. Key investors include Lab14 GmbH, RSBG SE, BICO Group (Former), ZEISS International (Former).

Who is the CEO of Nanoscribe?

Martin Hermatschweiler is the CEO of Nanoscribe. The company was founded in 2007.

Where is Nanoscribe located?

Nanoscribe is headquartered in Eggenstein-Leopoldshafen, Germany.

What funding stage is Nanoscribe at?

Nanoscribe is currently at the Acquired stage.

How many employees does Nanoscribe have?

Nanoscribe has approximately 51-200 employees.

Nanoscribe

Name: AM Companies Database
Creator: AMPulse
License: https://creativecommons.org/licenses/by/4.0/

HardwareEggenstein-Leopoldshafen, GermanyFounded 2007· One of 1738 Hardware companies tracked by AMPulse

A global leader in high-precision 3D microfabrication, providing laser-based 3D printers that enable sub-micrometer resolution for industrial and scientific applications.

CEO / Founder: Martin Hermatschweiler
Team Size: 51-200
Stage: Acquired
Total Funding: $86.5M
Latest Round: Acquired
Key Investors: Lab14 GmbH, RSBG SE, BICO Group (Former), ZEISS International (Former)

Technology & Products

Key Products

["Quantum X platform (High-speed microfabrication for micro-optics)","Quantum X bio (High-resolution 3D bioprinter for life sciences)","Quantum X align (High-precision alignment for fiber-to-chip coupling)","Photonic Professional GT2 (Versatile high-resolution 3D micro-printer)","IP-Resins (Proprietary photoresists and specialty printing materials)","Nanoscribe Nano-Print Solutions (Software and process support)"]

Technological Advantage

Proprietary Two-Photon Grayscale Lithography (2PGL) technology allows for ultra-smooth optical surfaces and high-speed voxel placement, significantly reducing production time compared to traditional 2PP methods.

Differentiation

Value Proposition

Enables the fabrication of complex 3D microstructures with sub-micron precision and optical-grade surface smoothness, bridging the gap between traditional micro-lithography and 3D printing.

How They Differentiate

Proprietary Two-Photon Grayscale Lithography (2PGL) technology which allows for ultra-smooth optical surfaces and significantly higher throughput than traditional 2PP methods.

Market & Competition

Target Customers

Research universities, government laboratories, and industrial R&D departments in photonics, medical device manufacturing, and micro-electronics.

Industry Verticals

["Micro-optics","Integrated Photonics","Life Sciences & Bioprinting","Micro-Electro-Mechanical Systems (MEMS)","Materials Science","Medical Technology"]

Competitors

UpNano; Microlight3D; Heidelberg Instruments (Multiphoton Optics); Boston Micro Fabrication (BMF)

Growth & Milestones

Growth Metrics

Over 400 systems installed globally; Annual revenue approximately €20M (SEK 230M) as of late 2024.

Major Milestones

["Founded in 2007 as a spin-off from Karlsruhe Institute of Technology (KIT)","Launched Quantum X in 2019, the first industrial system with 2PGL technology","Acquired by BICO Group in May 2021 for €50M","Inaugurated a new Microfabrication Experience Center in China in 2024","Acquired by Lab14 GmbH (a subsidiary of RSBG SE) in November 2024 for €26M"]

Notable Customers

Harvard University; Stanford University; ETH Zurich; Max Planck Institute; ZEISS; Nikon

https://www.nanoscribe.com

Recent coverage of Nanoscribe

Why this company matters

Nanoscribe occupies a premium position in additive manufacturing as the pioneer and global market leader in two-photon polymerization (2PP) 3D printing. Founded in 2007 as a spin-off from the Karlsruhe Institute of Technology, the company bridges the gap between traditional micro-lithography and 3D printing by enabling the fabrication of complex microstructures with sub-micron precision and optical-grade surface smoothness.

The company's core technology is Two-Photon Grayscale Lithography (2PGL), a proprietary advancement over conventional 2PP that allows for ultra-smooth optical surfaces and high-speed voxel placement. This is embodied in the Quantum X platform, which targets high-speed microfabrication for micro-optics, fiber-to-chip alignment, and bioprinting. The Photonic Professional GT2 serves as a versatile high-resolution micro-printer for research and development. Nanoscribe also produces proprietary IP-Resins photoresists and offers Nano-Print Solutions software and process support.

Customers include leading research universities such as Harvard, Stanford, and ETH Zurich, as well as industrial partners like ZEISS and Nikon. Applications span micro-optics, integrated photonics, life sciences and bioprinting, MEMS, materials science, and medical technology. With over 400 systems installed globally and annual revenue of approximately €20 million as of late 2024, the company serves both academic R&D and industrial manufacturing departments.

Nanoscribe's strategic moat rests on its proprietary 2PGL technology and a robust IP portfolio of over 50 patent families covering 3D laser lithography and 2PP processes. Key partnerships include ZEISS and Nikon for optics integration, and the company is now owned by Lab14 GmbH, a subsidiary of RSBG SE. A key open question is whether the company can extend its reach from research labs into high-volume industrial production for micro-optics and medical devices, where competitors like UpNano and Boston Micro Fabrication are also advancing.